Post by Evotec

🏆 We are pleased to announce the winner of the 2026 Evotec – SCT Prize for Excellence in Molecular Design, awarded under the patronage of the French Medchem Society Société de Chimie Thérapeutique SCT. Congratulations to Dr. Brian Lanman, Senior Director of Research in Small Molecule Therapeutic Discovery at Amgen and a leader in the discovery of targeted KRAS inhibitors, including LUMAKRAS® (sotorasib), the first FDA-approved KRAS G12C inhibitor, and AMG 410, a Phase 1 pan-KRAS inhibitor. Thank you and well done to all who participated this year!